Table 4 Multivariate adjusted risk estimation of different systolic and diastolic blood pressure and pulse pressure quartiles for CV-mortality in the total population and those with and without anti-hypertensive medication: Tehran Lipid and Glucose study (1999–2014)

Total (N = 1232)

SBP < 120

14/367

(0.47–2.23)

(0.51–2.42)

120 ≤ SBP < 130*

12/224

Ref

Ref

130 ≤ SBP < 140

13/211

(0.52–2.49)

(0.41–2.05)

SBP ≥ 140

61/430

(1.11–3.86)

(1.16–4.22)

DBP < 80

43/544

(1.46–9.34)

(1.17–7.7)

80 ≤ DBP < 85*

5/242

Ref

Ref

85 ≤ DBP < 90

17/165

(1.89–13.9)

(2.01–14.92)

DBP ≥ 90

35/281

(2.48–16.32)

(2.66–17.7)

PP < 40*

9/327

Ref

Ref

40 ≤ PP < 50

19/291

(0.76–3.76)

(0.7–3.54)

50 ≤ PP < 64

23/307

(0.68–3.27)

(0.57–2.75)

PP ≥ 64

49/307

(1.20–5.20)

(1.06–4.64)